Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2463474125;74126;74127 chr2:178572232;178572231;178572230chr2:179436959;179436958;179436957
N2AB2299369202;69203;69204 chr2:178572232;178572231;178572230chr2:179436959;179436958;179436957
N2A2206666421;66422;66423 chr2:178572232;178572231;178572230chr2:179436959;179436958;179436957
N2B1556946930;46931;46932 chr2:178572232;178572231;178572230chr2:179436959;179436958;179436957
Novex-11569447305;47306;47307 chr2:178572232;178572231;178572230chr2:179436959;179436958;179436957
Novex-21576147506;47507;47508 chr2:178572232;178572231;178572230chr2:179436959;179436958;179436957
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: TCA
  • RefSeq wild type template codon: AGT
  • Domain: Fn3-67
  • Domain position: 19
  • Structural Position: 21
  • Q(SASA): 0.1289
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/P rs1387907795 -0.259 0.984 N 0.601 0.318 0.390531646278 gnomAD-2.1.1 4.04E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.94E-06 0
S/P rs1387907795 -0.259 0.984 N 0.601 0.318 0.390531646278 gnomAD-4.0.0 1.59208E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85946E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.1038 likely_benign 0.0979 benign -0.732 Destabilizing 0.119 N 0.423 neutral N 0.48544645 None None N
S/C 0.1159 likely_benign 0.109 benign -0.733 Destabilizing 0.999 D 0.641 neutral None None None None N
S/D 0.6913 likely_pathogenic 0.6546 pathogenic -1.051 Destabilizing 0.921 D 0.513 neutral None None None None N
S/E 0.7277 likely_pathogenic 0.7132 pathogenic -1.001 Destabilizing 0.943 D 0.509 neutral None None None None N
S/F 0.2052 likely_benign 0.1909 benign -0.856 Destabilizing 0.997 D 0.678 prob.neutral None None None None N
S/G 0.1661 likely_benign 0.1428 benign -1.012 Destabilizing 0.956 D 0.517 neutral None None None None N
S/H 0.3451 ambiguous 0.3327 benign -1.513 Destabilizing 1.0 D 0.636 neutral None None None None N
S/I 0.1534 likely_benign 0.1423 benign -0.078 Destabilizing 0.987 D 0.627 neutral None None None None N
S/K 0.6932 likely_pathogenic 0.6583 pathogenic -0.698 Destabilizing 0.978 D 0.512 neutral None None None None N
S/L 0.1024 likely_benign 0.0883 benign -0.078 Destabilizing 0.943 D 0.582 neutral N 0.496239447 None None N
S/M 0.1653 likely_benign 0.1505 benign 0.1 Stabilizing 0.999 D 0.639 neutral None None None None N
S/N 0.2087 likely_benign 0.1867 benign -0.924 Destabilizing 0.579 D 0.529 neutral None None None None N
S/P 0.947 likely_pathogenic 0.9326 pathogenic -0.262 Destabilizing 0.984 D 0.601 neutral N 0.486652337 None None N
S/Q 0.5173 ambiguous 0.5095 ambiguous -1.043 Destabilizing 0.997 D 0.573 neutral None None None None N
S/R 0.6152 likely_pathogenic 0.5799 pathogenic -0.664 Destabilizing 0.994 D 0.598 neutral None None None None N
S/T 0.0715 likely_benign 0.0605 benign -0.791 Destabilizing None N 0.282 neutral N 0.380297711 None None N
S/V 0.1626 likely_benign 0.1497 benign -0.262 Destabilizing 0.891 D 0.576 neutral None None None None N
S/W 0.4141 ambiguous 0.4052 ambiguous -0.912 Destabilizing 1.0 D 0.765 deleterious None None None None N
S/Y 0.2242 likely_benign 0.2168 benign -0.578 Destabilizing 0.997 D 0.687 prob.neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.